David KirnOfficer
Traded Oct 5 · filed the same day
A 4d Molecular Therapeutics officer told the SEC about a plan to sell $754K of 4d Molecular Therapeutics shares around Oct 5, 2026. The shares were not acquired as compensation. That is 0.1% of all 4d Molecular Therapeutics shares.